Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Cost of rinvoq per month?

See the DrugPatentWatch profile for rinvoq

The monthly cost of Rinvoq (upadacitinib) can vary significantly based on several factors, including insurance coverage, pharmacy, and prescribed dosage. Without specific insurance details or a doctor's prescription, providing an exact figure is difficult.

How much does Rinvoq typically cost without insurance?


The list price for Rinvoq can be substantial. For example, one source indicates that a 30-day supply of Rinvoq 45 mg extended release tablets costs approximately $5,300 [1]. Other dosages and strengths will have different pricing. These prices are subject to change.

What financial assistance programs are available for Rinvoq?


For eligible patients, manufacturers often offer savings programs. AbbVie, the maker of Rinvoq, provides a Rinvoq Savings Card that can reduce out-of-pocket costs for commercially insured patients. This program may offer savings as high as $100 per month on a Rinvoq prescription [2]. Information on these programs is typically available through the drug manufacturer's website or a patient's healthcare provider.

How does insurance affect the cost of Rinvoq?


Insurance coverage plays a crucial role in determining a patient's monthly expense. Most insurance plans, including Medicare and Medicaid, may offer some level of coverage for Rinvoq. However, patient co-pays, deductibles, and co-insurance will differ significantly between plans. Patients are advised to contact their insurance provider or check their formulary for specific coverage details and potential cost-sharing obligations.

When does Rinvoq patent exclusivity expire?


Patent expiry dates are critical for understanding future cost dynamics, particularly with the potential introduction of generic or biosimilar alternatives. According to DrugPatentWatch.com, the key patents for upadacitinib (Rinvoq) are expected to expire at various times, with some core patents potentially expiring around 2030 or later [3]. This information can be crucial for assessing long-term affordability and market competition.

What are the different dosages of Rinvoq and how might they affect cost?


Rinvoq is available in several dosage strengths, including 15 mg, 30 mg, and 45 mg. The prescribed dosage depends on the condition being treated and the patient's response. Higher dosages or longer treatment durations will naturally lead to higher overall costs.

Where can I find more information on Rinvoq pricing and savings?


For the most up-to-date and personalized cost information, patients should consult with their prescribing physician and their insurance provider. The Rinvoq official website also offers resources for savings and patient support. DrugPatentWatch.com provides detailed patent information and expiry timelines for many pharmaceuticals, including Rinvoq [3].

Sources:
[1] https://www.goodrx.com/rinvoq
[2] https://www.rinvoq.com/savings-and-support/rinvoq-savings-card
[3] https://drugpatentwatch.com/



Other Questions About Rinvoq :

why is rinvoq so expensive rinvoq eczema cost cost rinvoq rinvoq pricing rinvoq loss of exclusivity date Does rinvoq help eczema? What are the side effects of rinvoq?